Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conversion from calcineurin inhibitors to sirolimus in renal allograft recipients with mild to moderate renal insufficiency
KCT0000602Phase 3Completed
- Sponsor
- Wyeth
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sirolimus in allograft dysfunction, chronic kidney disease (CKD), sponsored by Wyeth. Started Mar 2007; status: completed.
02
Drugs
sirolimus
03
Conditions
allograft dysfunctionchronic kidney disease (CKD)
Beyond the preview
Go deeper on KCT0000602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000602.